Bessemer Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22K | Buy |
967
+356
| +58% | +$7.91K | ﹤0.01% | 1909 |
|
|
2025
Q4 | $15K | Buy |
611
+216
| +55% | +$5.14K | ﹤0.01% | 1975 |
|
|
2025
Q3 | $10K | Buy |
395
+28
| +8% | +$688 | ﹤0.01% | 1953 |
|
|
2025
Q2 | $9K | Buy |
367
+54
| +17% | +$1.36K | ﹤0.01% | 1864 |
|
|
2025
Q1 | $8K | Buy |
313
+67
| +27% | +$1.6K | ﹤0.01% | 1872 |
|
|
2024
Q4 | $5K | Hold |
246
| – | – | ﹤0.01% | 2012 |
|
|
2024
Q3 | $4K | Buy |
246
+6
| +3% | +$103 | ﹤0.01% | 2025 |
|
|
2024
Q2 | $7K | Buy |
240
+97
| +68% | +$2.76K | ﹤0.01% | 1623 |
|
|
2024
Q1 | $4K | Buy |
143
+33
| +30% | +$1.01K | ﹤0.01% | 1789 |
|
|
2023
Q4 | $4K | Hold |
110
| – | – | ﹤0.01% | 1844 |
|
|
2023
Q3 | $3K | Buy |
110
+70
| +175% | +$2.52K | ﹤0.01% | 1895 |
|
|
2023
Q2 | $2K | Buy |
+40
| New | +$1.65K | ﹤0.01% | 2058 |
|
|
2022
Q4 | – | Sell |
-59,674
| Closed | -$3.17M | – | 2090 |
|
|
2022
Q3 | $3.17M | Buy |
59,674
+59,608
| +90,315% | +$3.31M | 0.01% | 384 |
|
|
2022
Q2 | $4K | Hold |
66
| – | – | ﹤0.01% | 1620 |
|
|
2022
Q1 | $5K | Sell |
66
-4
| -6% | -$267 | ﹤0.01% | 1538 |
|
|
2021
Q4 | $4K | Buy |
+70
| New | +$3.86K | ﹤0.01% | 1667 |
|
|
2021
Q3 | – | Sell |
-61
| Closed | -$4K | – | 1735 |
|
|
2021
Q2 | $4K | Sell |
61
-87
| -59% | -$5.51K | ﹤0.01% | 1453 |
|
|
2021
Q1 | $10K | Hold |
148
| – | – | ﹤0.01% | 1308 |
|
|
2020
Q4 | $9K | Buy |
+148
| New | +$8.67K | ﹤0.01% | 1309 |
|
|
2020
Q3 | – | Sell |
-12,700
| Closed | -$666K | – | 1588 |
|
|
2020
Q2 | $666K | Hold |
12,700
| – | – | ﹤0.01% | 903 |
|
|
2020
Q1 | $426K | Buy |
+12,700
| New | +$528K | ﹤0.01% | 822 |
|
|
2019
Q2 | – | Sell |
-24,000
| Closed | -$913K | – | 1770 |
|
|
2019
Q1 | $913K | Sell |
24,000
-265
| -1% | -$10.3K | ﹤0.01% | 656 |
|
|
2018
Q4 | $1.04M | Buy |
24,265
+24,000
| +9,057% | +$1.12M | ﹤0.01% | 562 |
|
|
2018
Q3 | $13K | Buy |
+265
| New | +$11.5K | ﹤0.01% | 1562 |
|
|
2017
Q4 | – | Sell |
-362
| Closed | -$14K | – | 1785 |
|
|
2017
Q3 | $14K | Hold |
362
| – | – | ﹤0.01% | 1556 |
|
|
2017
Q2 | $17K | Buy |
+362
| New | +$16.8K | ﹤0.01% | 1511 |
|
|
2017
Q1 | – | Sell |
-295
| Closed | -$10K | – | 1875 |
|
|
2016
Q4 | $10K | Buy |
295
+222
| +304% | +$7.41K | ﹤0.01% | 1641 |
|
|
2016
Q3 | $3K | Sell |
73
-1
| -1% | -$39 | ﹤0.01% | 1703 |
|
|
2016
Q2 | $3K | Sell |
74
-391
| -84% | -$19.2K | ﹤0.01% | 1230 |
|
|
2016
Q1 | $25K | Buy |
465
+389
| +512% | +$22.8K | ﹤0.01% | 1022 |
|
|
2015
Q4 | $6K | Hold |
76
| – | – | ﹤0.01% | 1329 |
|
|
2015
Q3 | $3K | Buy |
76
+30
| +65% | +$1.84K | ﹤0.01% | 1422 |
|
|
2015
Q2 | $3K | Buy |
+46
| New | +$3.62K | ﹤0.01% | 1424 |
|
Other funds holding PCRX
DPCM
VPM
VCM
